North America Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Analysis (2018-2024)
The North America Minimally Invasive Glaucoma Surgery (MIGS) Devices Market would witness market growth of 29.5% CAGR during the forecast period (2018 – 2024). Minimally invasive glaucoma surgery (MIGS) devices are used to treat glaucoma to provide a safer and lesser invasive means of reducing intraocular pressure (IOP), as compared to conventional glaucoma surgery devices. MIGS devices would be most preferred surgical modality during the forecast period to treat glaucoma. It limits the dependency on conventional medications as well as cuts the complications associated with traditional procedures. Glaucoma is a progressive disease and is the major cause of irreversible blindness with an estimated burden to rise 111.8 million by 2040. This has increased the demand for MIGS devices in the treatment of glaucoma.
The factors driving the market include rapid rise in geriatric population, who are more prone to ophthalmology diseases such as glaucoma and cataract. The novel paradigm of glaucoma therapy by using MIGS devices will aspire to a much reduced dependence on topical medication. In addition, increasing preference of surgeons for MIGS is adding boost to the market growth.
On the basis of Surgery, the market is segmented into Glaucoma in Conjunction with Cataract and Stand Alone Glaucoma. Target is categorized into Trabecular Meshwork, Suprachoroidal Space and Other Targets. On the basis of Product, the market is segmented into MIGS Stents, MIGS Shunts and Other Products. The End Users covered under the report are Eye Hospitals, Ophthalmology Clinics and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Prominent players offering minimally invasive glaucoma surgery (MIGS) devices include Ellex Medical Lasers Ltd, Allergan Plc, Santen Pharmaceutical Co., Ltd., Glaukos Corporation, Alcon Inc. (Novartis), Lumenis, Ivantis, Inc., iSTAR Medical, InnFocus Inc., and SOLX, Inc.
The factors driving the market include rapid rise in geriatric population, who are more prone to ophthalmology diseases such as glaucoma and cataract. The novel paradigm of glaucoma therapy by using MIGS devices will aspire to a much reduced dependence on topical medication. In addition, increasing preference of surgeons for MIGS is adding boost to the market growth.
On the basis of Surgery, the market is segmented into Glaucoma in Conjunction with Cataract and Stand Alone Glaucoma. Target is categorized into Trabecular Meshwork, Suprachoroidal Space and Other Targets. On the basis of Product, the market is segmented into MIGS Stents, MIGS Shunts and Other Products. The End Users covered under the report are Eye Hospitals, Ophthalmology Clinics and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Prominent players offering minimally invasive glaucoma surgery (MIGS) devices include Ellex Medical Lasers Ltd, Allergan Plc, Santen Pharmaceutical Co., Ltd., Glaukos Corporation, Alcon Inc. (Novartis), Lumenis, Ivantis, Inc., iSTAR Medical, InnFocus Inc., and SOLX, Inc.
CHAPTER 1. MARKET SCOPE & METHODOLOGY
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, by Surgery
1.4.2 North America Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, by Target
1.4.3 North America Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, by Product
1.4.4 North America Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, by End User
1.4.5 North America Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, by Country
1.5 Methodology for the research
CHAPTER 2. MARKET OVERVIEW
2.1 Introduction
2.2 Drivers, and Restraints
2.2.1 Market Drivers
2.2.2 Market Restraints
CHAPTER 3. NORTH AMERICA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET BY SURGERY
3.1.1 North America Glaucoma in Conjunction with Cataract Market by Country
3.1.2 North America Stand Alone Glaucoma Market by Country
CHAPTER 4. NORTH AMERICA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET BY TARGET
4.1.1 North America Trabecular Meshwork Market by Country
4.1.2 North America Suprachoroidal Space Market by Country
4.1.3 North America Other Targets Market by Country
CHAPTER 5. NORTH AMERICA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET BY PRODUCT
5.1.1 North America MIGS Stents Market by Country
5.1.2 North America MIGS Shunts Market by Country
5.1.3 North America Other Products Market by Country
CHAPTER 6. NORTH AMERICA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET BY END USER
6.1.1 North America Eye Hospitals Market by Country
6.1.2 North America Ophthalmology Clinics Market by Country
6.1.3 North America Minimally Invasive Glaucoma Surgery (MIGS) Devices in Other End User Market by Country
CHAPTER 7. NORTH AMERICA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET BY COUNTRY
7.1 USA Minimally Invasive Glaucoma Surgery (MIGS) Devices Market
7.1.1 USA Minimally Invasive Glaucoma Surgery (MIGS) Devices Market by Surgery
7.1.2 USA Minimally Invasive Glaucoma Surgery (MIGS) Devices Market by Target
7.1.3 USA Minimally Invasive Glaucoma Surgery (MIGS) Devices Market by Product
7.1.4 USA Minimally Invasive Glaucoma Surgery (MIGS) Devices Market by End User
7.2 Canada Minimally Invasive Glaucoma Surgery (MIGS) Devices Market
7.2.1 Canada Minimally Invasive Glaucoma Surgery (MIGS) Devices Market by Surgery
7.2.2 Canada Minimally Invasive Glaucoma Surgery (MIGS) Devices Market by Target
7.2.3 Canada Minimally Invasive Glaucoma Surgery (MIGS) Devices Market by Product
7.2.4 Canada Minimally Invasive Glaucoma Surgery (MIGS) Devices Market by End User
7.3 Mexico Minimally Invasive Glaucoma Surgery (MIGS) Devices Market
7.3.1 Mexico Minimally Invasive Glaucoma Surgery (MIGS) Devices Market by Surgery
7.3.2 Mexico Minimally Invasive Glaucoma Surgery (MIGS) Devices Market by Target
7.3.3 Mexico Minimally Invasive Glaucoma Surgery (MIGS) Devices Market by Product
7.3.4 Mexico Minimally Invasive Glaucoma Surgery (MIGS) Devices Market by End User
7.4 Rest of North America Minimally Invasive Glaucoma Surgery (MIGS) Devices Market
7.4.1 Rest of North America Minimally Invasive Glaucoma Surgery (MIGS) Devices Market by Surgery
7.4.2 Rest of North America Minimally Invasive Glaucoma Surgery (MIGS) Devices Market by Target
7.4.3 Rest of North America Minimally Invasive Glaucoma Surgery (MIGS) Devices Market by Product
7.4.4 Rest of North America Minimally Invasive Glaucoma Surgery (MIGS) Devices Market by End User
CHAPTER 8. COMPANY PROFILE
8.1 Ellex Medical Lasers Ltd.
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expense
8.2 Allergan Plc.
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental Analysis
8.2.4 Research & Development Expense
8.3 Santen Pharmaceutical Co., Ltd.
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental and Regional Analysis
8.3.4 Research & Development Expense
8.4 Glaukos Corporation
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Regional Analysis
8.4.4 Research & Development Expense
8.5 Novartis AG (Alcon Inc.)
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental and Regional Analysis
8.5.4 Research & Development Expense
8.6 Lumenis Ltd.
8.6.1 Company Overview
8.7 iSTAR Medical
8.7.1 Company Overview
8.8 Ivantis, Inc.
8.8.1 Company Overview
8.9 SOLX, Inc.
8.9.1 Company Overview
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, by Surgery
1.4.2 North America Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, by Target
1.4.3 North America Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, by Product
1.4.4 North America Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, by End User
1.4.5 North America Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, by Country
1.5 Methodology for the research
CHAPTER 2. MARKET OVERVIEW
2.1 Introduction
2.2 Drivers, and Restraints
2.2.1 Market Drivers
2.2.2 Market Restraints
CHAPTER 3. NORTH AMERICA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET BY SURGERY
3.1.1 North America Glaucoma in Conjunction with Cataract Market by Country
3.1.2 North America Stand Alone Glaucoma Market by Country
CHAPTER 4. NORTH AMERICA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET BY TARGET
4.1.1 North America Trabecular Meshwork Market by Country
4.1.2 North America Suprachoroidal Space Market by Country
4.1.3 North America Other Targets Market by Country
CHAPTER 5. NORTH AMERICA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET BY PRODUCT
5.1.1 North America MIGS Stents Market by Country
5.1.2 North America MIGS Shunts Market by Country
5.1.3 North America Other Products Market by Country
CHAPTER 6. NORTH AMERICA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET BY END USER
6.1.1 North America Eye Hospitals Market by Country
6.1.2 North America Ophthalmology Clinics Market by Country
6.1.3 North America Minimally Invasive Glaucoma Surgery (MIGS) Devices in Other End User Market by Country
CHAPTER 7. NORTH AMERICA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET BY COUNTRY
7.1 USA Minimally Invasive Glaucoma Surgery (MIGS) Devices Market
7.1.1 USA Minimally Invasive Glaucoma Surgery (MIGS) Devices Market by Surgery
7.1.2 USA Minimally Invasive Glaucoma Surgery (MIGS) Devices Market by Target
7.1.3 USA Minimally Invasive Glaucoma Surgery (MIGS) Devices Market by Product
7.1.4 USA Minimally Invasive Glaucoma Surgery (MIGS) Devices Market by End User
7.2 Canada Minimally Invasive Glaucoma Surgery (MIGS) Devices Market
7.2.1 Canada Minimally Invasive Glaucoma Surgery (MIGS) Devices Market by Surgery
7.2.2 Canada Minimally Invasive Glaucoma Surgery (MIGS) Devices Market by Target
7.2.3 Canada Minimally Invasive Glaucoma Surgery (MIGS) Devices Market by Product
7.2.4 Canada Minimally Invasive Glaucoma Surgery (MIGS) Devices Market by End User
7.3 Mexico Minimally Invasive Glaucoma Surgery (MIGS) Devices Market
7.3.1 Mexico Minimally Invasive Glaucoma Surgery (MIGS) Devices Market by Surgery
7.3.2 Mexico Minimally Invasive Glaucoma Surgery (MIGS) Devices Market by Target
7.3.3 Mexico Minimally Invasive Glaucoma Surgery (MIGS) Devices Market by Product
7.3.4 Mexico Minimally Invasive Glaucoma Surgery (MIGS) Devices Market by End User
7.4 Rest of North America Minimally Invasive Glaucoma Surgery (MIGS) Devices Market
7.4.1 Rest of North America Minimally Invasive Glaucoma Surgery (MIGS) Devices Market by Surgery
7.4.2 Rest of North America Minimally Invasive Glaucoma Surgery (MIGS) Devices Market by Target
7.4.3 Rest of North America Minimally Invasive Glaucoma Surgery (MIGS) Devices Market by Product
7.4.4 Rest of North America Minimally Invasive Glaucoma Surgery (MIGS) Devices Market by End User
CHAPTER 8. COMPANY PROFILE
8.1 Ellex Medical Lasers Ltd.
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expense
8.2 Allergan Plc.
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental Analysis
8.2.4 Research & Development Expense
8.3 Santen Pharmaceutical Co., Ltd.
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental and Regional Analysis
8.3.4 Research & Development Expense
8.4 Glaukos Corporation
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Regional Analysis
8.4.4 Research & Development Expense
8.5 Novartis AG (Alcon Inc.)
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental and Regional Analysis
8.5.4 Research & Development Expense
8.6 Lumenis Ltd.
8.6.1 Company Overview
8.7 iSTAR Medical
8.7.1 Company Overview
8.8 Ivantis, Inc.
8.8.1 Company Overview
8.9 SOLX, Inc.
8.9.1 Company Overview
LIST OF TABLES
Table 1 NORTH AMERICA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, 2014 - 2017, USD MILLION
Table 2 NORTH AMERICA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, 2018 - 2024, USD MILLION
Table 3 NORTH AMERICA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET BY SURGERY, 2014 - 2017, USD MILLION
Table 4 NORTH AMERICA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET BY SURGERY, 2018 - 2024, USD MILLION
Table 5 NORTH AMERICA GLAUCOMA IN CONJUNCTION WITH CATARACT MARKET BY COUNTRY, 2014 - 2017, USD MILLION
Table 6 NORTH AMERICA GLAUCOMA IN CONJUNCTION WITH CATARACT MARKET BY COUNTRY, 2018 - 2024, USD MILLION
Table 7 NORTH AMERICA STAND ALONE GLAUCOMA MARKET BY COUNTRY, 2014 - 2017, USD MILLION
Table 8 NORTH AMERICA STAND ALONE GLAUCOMA MARKET BY COUNTRY, 2018 - 2024, USD MILLION
Table 9 NORTH AMERICA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET BY TARGET, 2014 - 2017, USD MILLION
Table 10 NORTH AMERICA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET BY TARGET, 2018 - 2024, USD MILLION
Table 11 NORTH AMERICA TRABECULAR MESHWORK MARKET BY COUNTRY, 2014 - 2017, USD MILLION
Table 12 NORTH AMERICA TRABECULAR MESHWORK MARKET BY COUNTRY, 2018 - 2024, USD MILLION
Table 13 NORTH AMERICA SUPRACHOROIDAL SPACE MARKET BY COUNTRY, 2014 - 2017, USD MILLION
Table 14 NORTH AMERICA SUPRACHOROIDAL SPACE MARKET BY COUNTRY, 2018 - 2024, USD MILLION
Table 15 NORTH AMERICA OTHER TARGETS MARKET BY COUNTRY, 2014 - 2017, USD MILLION
Table 16 NORTH AMERICA OTHER TARGETS MARKET BY COUNTRY, 2018 - 2024, USD MILLION
Table 17 NORTH AMERICA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET BY PRODUCT, 2014 - 2017, USD MILLION
Table 18 NORTH AMERICA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET BY PRODUCT, 2018 - 2024, USD MILLION
Table 19 NORTH AMERICA MIGS STENTS MARKET BY COUNTRY, 2014 - 2017, USD MILLION
Table 20 NORTH AMERICA MIGS STENTS MARKET BY COUNTRY, 2018 - 2024, USD MILLION
Table 21 NORTH AMERICA MIGS SHUNTS MARKET BY COUNTRY, 2014 - 2017, USD MILLION
Table 22 NORTH AMERICA MIGS SHUNTS MARKET BY COUNTRY, 2018 - 2024, USD MILLION
Table 23 NORTH AMERICA OTHER PRODUCTS MARKET BY COUNTRY, 2014 - 2017, USD MILLION
Table 24 NORTH AMERICA OTHER PRODUCTS MARKET BY COUNTRY, 2018 - 2024, USD MILLION
Table 25 NORTH AMERICA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET BY END USER, 2014 - 2017, USD MILLION
Table 26 NORTH AMERICA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET BY END USER, 2018 - 2024, USD MILLION
Table 27 NORTH AMERICA EYE HOSPITALS MARKET BY COUNTRY, 2014 - 2017, USD MILLION
Table 28 NORTH AMERICA EYE HOSPITALS MARKET BY COUNTRY, 2018 - 2024, USD MILLION
Table 29 NORTH AMERICA OPHTHALMOLOGY CLINICS MARKET BY COUNTRY, 2014 - 2017, USD MILLION
Table 30 NORTH AMERICA OPHTHALMOLOGY CLINICS MARKET BY COUNTRY, 2018 - 2024, USD MILLION
Table 31 NORTH AMERICA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES IN OTHER END USER MARKET BY COUNTRY, 2014 - 2017, USD MILLION
Table 32 NORTH AMERICA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES IN OTHER END USER MARKET BY COUNTRY, 2018 - 2024, USD MILLION
Table 33 NORTH AMERICA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET BY COUNTRY, 2014 - 2017, USD MILLION
Table 34 NORTH AMERICA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET BY COUNTRY, 2018 - 2024, USD MILLION
Table 35 USA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, 2014 - 2017, USD MILLION
Table 36 USA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, 2018 - 2024, USD MILLION
Table 37 USA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET BY SURGERY, 2014 - 2017, USD MILLION
Table 38 USA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET BY SURGERY, 2018 - 2024, USD MILLION
Table 39 USA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET BY TARGET, 2014 - 2017, USD MILLION
Table 40 USA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET BY TARGET, 2018 - 2024, USD MILLION
Table 41 USA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET BY PRODUCT, 2014 - 2017, USD MILLION
Table 42 USA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET BY PRODUCT, 2018 - 2024, USD MILLION
Table 43 USA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET BY END USER, 2014 - 2017, USD MILLION
Table 44 USA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET BY END USER, 2018 - 2024, USD MILLION
Table 45 CANADA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, 2014 - 2017, USD MILLION
Table 46 CANADA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, 2018 - 2024, USD MILLION
Table 47 CANADA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET BY SURGERY, 2014 - 2017, USD MILLION
Table 48 CANADA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET BY SURGERY, 2018 - 2024, USD MILLION
Table 49 CANADA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET BY TARGET, 2014 - 2017, USD MILLION
Table 50 CANADA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET BY TARGET, 2018 - 2024, USD MILLION
Table 51 CANADA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET BY PRODUCT, 2014 - 2017, USD MILLION
Table 52 CANADA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET BY PRODUCT, 2018 - 2024, USD MILLION
Table 53 CANADA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET BY END USER, 2014 - 2017, USD MILLION
Table 54 CANADA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET BY END USER, 2018 - 2024, USD MILLION
Table 55 MEXICO MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, 2014 - 2017, USD MILLION
Table 56 MEXICO MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, 2018 - 2024, USD MILLION
Table 57 MEXICO MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET BY SURGERY, 2014 - 2017, USD MILLION
Table 58 MEXICO MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET BY SURGERY, 2018 - 2024, USD MILLION
Table 59 MEXICO MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET BY TARGET, 2014 - 2017, USD MILLION
Table 60 MEXICO MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET BY TARGET, 2018 - 2024, USD MILLION
Table 61 MEXICO MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET BY PRODUCT, 2014 - 2017, USD MILLION
Table 62 MEXICO MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET BY PRODUCT, 2018 - 2024, USD MILLION
Table 63 MEXICO MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET BY END USER, 2014 - 2017, USD MILLION
Table 64 MEXICO MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET BY END USER, 2018 - 2024, USD MILLION
Table 65 REST OF NORTH AMERICA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, 2014 - 2017, USD MILLION
Table 66 REST OF NORTH AMERICA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, 2018 - 2024, USD MILLION
Table 67 REST OF NORTH AMERICA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET BY SURGERY, 2014 - 2017, USD MILLION
Table 68 REST OF NORTH AMERICA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET BY SURGERY, 2018 - 2024, USD MILLION
Table 69 REST OF NORTH AMERICA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET BY TARGET, 2014 - 2017, USD MILLION
Table 70 REST OF NORTH AMERICA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET BY TARGET, 2018 - 2024, USD MILLION
Table 71 REST OF NORTH AMERICA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET BY PRODUCT, 2014 - 2017, USD MILLION
Table 72 REST OF NORTH AMERICA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET BY PRODUCT, 2018 - 2024, USD MILLION
Table 73 REST OF NORTH AMERICA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET BY END USER, 2014 - 2017, USD MILLION
Table 74 REST OF NORTH AMERICA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET BY END USER, 2018 - 2024, USD MILLION
Table 75 KEY INFORMATION – ELLEX MEDICAL LASERS LTD.
Table 76 KEY INFORMATION – ALLERGAN PLC.
Table 77 KEY INFORMATION – SANTEN PHARMACEUTICAL CO., LTD.
Table 78 KEY INFORMATION – GLAUKOS CORPORATION
Table 79 KEY INFORMATION – NOVARTIS AG (ALCON INC.)
Table 80 KEY INFORMATION – LUMENIS LTD.
Table 81 KEY INFORMATION – ISTAR MEDICAL
Table 82 KEY INFORMATION – IVANTIS, INC.
Table 83 KEY INFORMATION – SOLX, INC.
Table 1 NORTH AMERICA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, 2014 - 2017, USD MILLION
Table 2 NORTH AMERICA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, 2018 - 2024, USD MILLION
Table 3 NORTH AMERICA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET BY SURGERY, 2014 - 2017, USD MILLION
Table 4 NORTH AMERICA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET BY SURGERY, 2018 - 2024, USD MILLION
Table 5 NORTH AMERICA GLAUCOMA IN CONJUNCTION WITH CATARACT MARKET BY COUNTRY, 2014 - 2017, USD MILLION
Table 6 NORTH AMERICA GLAUCOMA IN CONJUNCTION WITH CATARACT MARKET BY COUNTRY, 2018 - 2024, USD MILLION
Table 7 NORTH AMERICA STAND ALONE GLAUCOMA MARKET BY COUNTRY, 2014 - 2017, USD MILLION
Table 8 NORTH AMERICA STAND ALONE GLAUCOMA MARKET BY COUNTRY, 2018 - 2024, USD MILLION
Table 9 NORTH AMERICA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET BY TARGET, 2014 - 2017, USD MILLION
Table 10 NORTH AMERICA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET BY TARGET, 2018 - 2024, USD MILLION
Table 11 NORTH AMERICA TRABECULAR MESHWORK MARKET BY COUNTRY, 2014 - 2017, USD MILLION
Table 12 NORTH AMERICA TRABECULAR MESHWORK MARKET BY COUNTRY, 2018 - 2024, USD MILLION
Table 13 NORTH AMERICA SUPRACHOROIDAL SPACE MARKET BY COUNTRY, 2014 - 2017, USD MILLION
Table 14 NORTH AMERICA SUPRACHOROIDAL SPACE MARKET BY COUNTRY, 2018 - 2024, USD MILLION
Table 15 NORTH AMERICA OTHER TARGETS MARKET BY COUNTRY, 2014 - 2017, USD MILLION
Table 16 NORTH AMERICA OTHER TARGETS MARKET BY COUNTRY, 2018 - 2024, USD MILLION
Table 17 NORTH AMERICA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET BY PRODUCT, 2014 - 2017, USD MILLION
Table 18 NORTH AMERICA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET BY PRODUCT, 2018 - 2024, USD MILLION
Table 19 NORTH AMERICA MIGS STENTS MARKET BY COUNTRY, 2014 - 2017, USD MILLION
Table 20 NORTH AMERICA MIGS STENTS MARKET BY COUNTRY, 2018 - 2024, USD MILLION
Table 21 NORTH AMERICA MIGS SHUNTS MARKET BY COUNTRY, 2014 - 2017, USD MILLION
Table 22 NORTH AMERICA MIGS SHUNTS MARKET BY COUNTRY, 2018 - 2024, USD MILLION
Table 23 NORTH AMERICA OTHER PRODUCTS MARKET BY COUNTRY, 2014 - 2017, USD MILLION
Table 24 NORTH AMERICA OTHER PRODUCTS MARKET BY COUNTRY, 2018 - 2024, USD MILLION
Table 25 NORTH AMERICA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET BY END USER, 2014 - 2017, USD MILLION
Table 26 NORTH AMERICA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET BY END USER, 2018 - 2024, USD MILLION
Table 27 NORTH AMERICA EYE HOSPITALS MARKET BY COUNTRY, 2014 - 2017, USD MILLION
Table 28 NORTH AMERICA EYE HOSPITALS MARKET BY COUNTRY, 2018 - 2024, USD MILLION
Table 29 NORTH AMERICA OPHTHALMOLOGY CLINICS MARKET BY COUNTRY, 2014 - 2017, USD MILLION
Table 30 NORTH AMERICA OPHTHALMOLOGY CLINICS MARKET BY COUNTRY, 2018 - 2024, USD MILLION
Table 31 NORTH AMERICA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES IN OTHER END USER MARKET BY COUNTRY, 2014 - 2017, USD MILLION
Table 32 NORTH AMERICA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES IN OTHER END USER MARKET BY COUNTRY, 2018 - 2024, USD MILLION
Table 33 NORTH AMERICA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET BY COUNTRY, 2014 - 2017, USD MILLION
Table 34 NORTH AMERICA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET BY COUNTRY, 2018 - 2024, USD MILLION
Table 35 USA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, 2014 - 2017, USD MILLION
Table 36 USA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, 2018 - 2024, USD MILLION
Table 37 USA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET BY SURGERY, 2014 - 2017, USD MILLION
Table 38 USA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET BY SURGERY, 2018 - 2024, USD MILLION
Table 39 USA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET BY TARGET, 2014 - 2017, USD MILLION
Table 40 USA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET BY TARGET, 2018 - 2024, USD MILLION
Table 41 USA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET BY PRODUCT, 2014 - 2017, USD MILLION
Table 42 USA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET BY PRODUCT, 2018 - 2024, USD MILLION
Table 43 USA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET BY END USER, 2014 - 2017, USD MILLION
Table 44 USA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET BY END USER, 2018 - 2024, USD MILLION
Table 45 CANADA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, 2014 - 2017, USD MILLION
Table 46 CANADA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, 2018 - 2024, USD MILLION
Table 47 CANADA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET BY SURGERY, 2014 - 2017, USD MILLION
Table 48 CANADA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET BY SURGERY, 2018 - 2024, USD MILLION
Table 49 CANADA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET BY TARGET, 2014 - 2017, USD MILLION
Table 50 CANADA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET BY TARGET, 2018 - 2024, USD MILLION
Table 51 CANADA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET BY PRODUCT, 2014 - 2017, USD MILLION
Table 52 CANADA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET BY PRODUCT, 2018 - 2024, USD MILLION
Table 53 CANADA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET BY END USER, 2014 - 2017, USD MILLION
Table 54 CANADA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET BY END USER, 2018 - 2024, USD MILLION
Table 55 MEXICO MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, 2014 - 2017, USD MILLION
Table 56 MEXICO MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, 2018 - 2024, USD MILLION
Table 57 MEXICO MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET BY SURGERY, 2014 - 2017, USD MILLION
Table 58 MEXICO MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET BY SURGERY, 2018 - 2024, USD MILLION
Table 59 MEXICO MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET BY TARGET, 2014 - 2017, USD MILLION
Table 60 MEXICO MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET BY TARGET, 2018 - 2024, USD MILLION
Table 61 MEXICO MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET BY PRODUCT, 2014 - 2017, USD MILLION
Table 62 MEXICO MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET BY PRODUCT, 2018 - 2024, USD MILLION
Table 63 MEXICO MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET BY END USER, 2014 - 2017, USD MILLION
Table 64 MEXICO MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET BY END USER, 2018 - 2024, USD MILLION
Table 65 REST OF NORTH AMERICA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, 2014 - 2017, USD MILLION
Table 66 REST OF NORTH AMERICA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, 2018 - 2024, USD MILLION
Table 67 REST OF NORTH AMERICA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET BY SURGERY, 2014 - 2017, USD MILLION
Table 68 REST OF NORTH AMERICA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET BY SURGERY, 2018 - 2024, USD MILLION
Table 69 REST OF NORTH AMERICA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET BY TARGET, 2014 - 2017, USD MILLION
Table 70 REST OF NORTH AMERICA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET BY TARGET, 2018 - 2024, USD MILLION
Table 71 REST OF NORTH AMERICA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET BY PRODUCT, 2014 - 2017, USD MILLION
Table 72 REST OF NORTH AMERICA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET BY PRODUCT, 2018 - 2024, USD MILLION
Table 73 REST OF NORTH AMERICA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET BY END USER, 2014 - 2017, USD MILLION
Table 74 REST OF NORTH AMERICA MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET BY END USER, 2018 - 2024, USD MILLION
Table 75 KEY INFORMATION – ELLEX MEDICAL LASERS LTD.
Table 76 KEY INFORMATION – ALLERGAN PLC.
Table 77 KEY INFORMATION – SANTEN PHARMACEUTICAL CO., LTD.
Table 78 KEY INFORMATION – GLAUKOS CORPORATION
Table 79 KEY INFORMATION – NOVARTIS AG (ALCON INC.)
Table 80 KEY INFORMATION – LUMENIS LTD.
Table 81 KEY INFORMATION – ISTAR MEDICAL
Table 82 KEY INFORMATION – IVANTIS, INC.
Table 83 KEY INFORMATION – SOLX, INC.
